JP2013510905A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013510905A5 JP2013510905A5 JP2012539974A JP2012539974A JP2013510905A5 JP 2013510905 A5 JP2013510905 A5 JP 2013510905A5 JP 2012539974 A JP2012539974 A JP 2012539974A JP 2012539974 A JP2012539974 A JP 2012539974A JP 2013510905 A5 JP2013510905 A5 JP 2013510905A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- affecting
- pta
- effective amount
- atcc deposit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26163909P | 2009-11-16 | 2009-11-16 | |
| US61/261,639 | 2009-11-16 | ||
| PCT/US2010/056862 WO2011060427A2 (en) | 2009-11-16 | 2010-11-16 | Composition and methods for affecting cytokines and nf-kb |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013510905A JP2013510905A (ja) | 2013-03-28 |
| JP2013510905A5 true JP2013510905A5 (enExample) | 2014-01-16 |
Family
ID=43992472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012539974A Pending JP2013510905A (ja) | 2009-11-16 | 2010-11-16 | サイトカイン及びｎｆ−ｋｂに影響を与える組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110117122A1 (enExample) |
| EP (1) | EP2501390A4 (enExample) |
| JP (1) | JP2013510905A (enExample) |
| BR (1) | BR112012011678A2 (enExample) |
| CA (1) | CA2780144A1 (enExample) |
| WO (1) | WO2011060427A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10166270B2 (en) | 2004-04-23 | 2019-01-01 | Zivo Bioscience, Inc. | Composition and method for affecting cytokines and NF-κB |
| CA2827401A1 (en) | 2010-02-22 | 2011-08-25 | Health Enhancement Products, Inc. | Agents and mechanisms for treating hypercholesterolemia |
| WO2014201372A1 (en) | 2013-06-13 | 2014-12-18 | Health Enhancement Products, Inc. | Compounds and methods for affecting cytokines |
| ES2972377T3 (es) | 2015-02-16 | 2024-06-12 | Zivo Bioscience Inc | Composiciones antinflamatorias e inmunomoduladoras que comprenden Klebsormidium y usos de las mismas |
| US11806375B2 (en) | 2016-02-16 | 2023-11-07 | Zivo Bioscience, Inc. | Nutritional support for animals via administration of an algal derived supplement |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9479A (en) * | 1852-12-21 | Improvement in rakes to grain-harvesters | ||
| US10480A (en) * | 1854-01-31 | Improvement in electro-magnettc engines | ||
| US15587A (en) * | 1856-08-19 | Aepabattts for boeing artesian wells | ||
| JPS6219528A (ja) * | 1985-07-16 | 1987-01-28 | Kurorera Kogyo Kk | 制癌剤 |
| US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| US6673908B1 (en) * | 1999-02-22 | 2004-01-06 | Nuvelo, Inc. | Tumor necrosis factor receptor 2 |
| WO2001013956A2 (en) * | 1999-08-26 | 2001-03-01 | Ganeden Biotech, Inc. | Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| AU7551100A (en) * | 1999-09-27 | 2001-04-30 | Algal Ltd. | Vegetarian foodstuff |
| EP1307213B1 (en) * | 2000-08-10 | 2004-04-28 | Ocean Nutrition Canada Ltd. | Chlorella preparations exhibiting immunomodulating properties |
| US20020119164A1 (en) * | 2000-08-18 | 2002-08-29 | Shoji Uchiyama | Use of agaricus blazei murill to prevent or treat skin and other disorders |
| US7125846B2 (en) * | 2001-11-09 | 2006-10-24 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides |
| EP1629090B1 (en) * | 2002-11-06 | 2014-03-05 | iBio, Inc. | Expression of foreign sequences in plants using trans-activation system |
| US20130251698A1 (en) * | 2010-10-04 | 2013-09-26 | Health Enhancement Products, Inc. | Composition and method for affecting cytokines and nf-kb |
| WO2005112987A2 (en) * | 2004-04-23 | 2005-12-01 | Health Enhancement Products, Inc. | Method of preparation and use of fibrinolytic enzymes in the treatment of disease |
| US7807622B2 (en) | 2004-04-23 | 2010-10-05 | Health Enhancement Products, Inc. | Composition and use of phyto-percolate for treatment of disease |
| CA2625818A1 (en) * | 2005-04-20 | 2006-10-26 | Health Enhancement Products, Inc. | Composition and use of phyto-percolate for treatment of disease |
| EP1954800A4 (en) * | 2005-12-02 | 2010-03-03 | Health Enhancement Products In | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE |
-
2010
- 2010-11-16 US US12/947,684 patent/US20110117122A1/en not_active Abandoned
- 2010-11-16 EP EP10830908.9A patent/EP2501390A4/en not_active Ceased
- 2010-11-16 WO PCT/US2010/056862 patent/WO2011060427A2/en not_active Ceased
- 2010-11-16 JP JP2012539974A patent/JP2013510905A/ja active Pending
- 2010-11-16 BR BR112012011678A patent/BR112012011678A2/pt not_active Application Discontinuation
- 2010-11-16 CA CA2780144A patent/CA2780144A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Watad et al. | Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity | |
| Chen et al. | Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis | |
| Moschen et al. | Interferon-alpha controls IL-17 expression in vitro and in vivo | |
| JP2014530226A5 (enExample) | ||
| JP2014513088A5 (enExample) | ||
| JP2009520029A5 (enExample) | ||
| EP3792280A3 (en) | Anti-blys antibody | |
| FI3250216T3 (fi) | Immunomoduloiva koostumus, joka käsittää bifidobakteereja | |
| JP2017519723A5 (enExample) | ||
| WO2014194226A3 (en) | Methods of treatment and compositions with xanthine oxidase inhibitors | |
| Karo et al. | Effects of miana (Coleus scutellariodes (L) Benth) to expression of mRNA IL-37 in Balb/c mice infected Candida albicans. | |
| Dey et al. | In vitro modulation of TH1 and TH2 cytokine expression by edible tuber of Dioscorea alata and study of correlation patterns of the cytokine expression | |
| MX2020008044A (es) | Células asesinas naturales resistentes al factor de crecimiento transformante beta. | |
| Zhang et al. | Effects of sodium tanshinone IIA sulfonate against Marek's disease virus in experimentally infected chickens | |
| JP2013100370A5 (enExample) | ||
| WO2013096732A3 (en) | Methods of treating or preventing viral diseases by blocking interleukin-21 | |
| JP2009518312A5 (enExample) | ||
| RU2010112734A (ru) | Способ элиминации бактерий gardnerella vaginalis и atopobium vaginae при бактериальном вагинозе | |
| Zhang et al. | PGBL inhibits the RAW 264.7 cells to express inflammatory factor | |
| Deng et al. | Enterococcus faecalis promotes osteoclast differentiation within an osteoblast/osteoclast co-culture system | |
| JP6255644B2 (ja) | 消化管免疫制御組成物 | |
| Xie et al. | Pinon shell polysaccharide enhances immunity against H9N2 avian influenza virus in chickens | |
| CN204379821U (zh) | 一种口腔溃疡膜贴片 | |
| Cerny et al. | Differential expression of mRNA encoding cytokines and chemokines in the reproductive tract after infection of mice with Chlamydia trachomatis | |
| Makhsous et al. | Study the kinetic of in vitro antibacterial activity of Salicornia spp. against Staphylococcus aureus strains |